Skip to main content
logo
MindMaze Therapeutics Holding SA (SWX:MMTX)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.1680
-0.0120 (-6.67%)
Sep 11, 2026, 5:30 PM CET

SWX:MMTX Revenue

In the year 2024, MindMaze Therapeutics Holding had annual revenue of 8.42M CHF with 39.52% growth.

Revenue
8.42M
Revenue Growth
+39.52%
P/S Ratio
23.88
Revenue / Employee
n/a
Employees
10
Market Cap
28.56M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20248.42M2.38M39.52%
Dec 31, 20236.03M-48.00K-0.79%
Dec 31, 20226.08M2.76M83.11%
Dec 31, 20213.32M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018565.00K--
Dec 31, 2017---
Dec 31, 201615.00K-242.23K-94.17%
Dec 31, 2015257.23K--
Dec 31, 2014---
Dec 31, 201320.74M-14.19M-40.62%
Dec 31, 201234.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bachem Holding AG708.53M
Basilea Pharmaceutica AG247.42M
Idorsia199.71M
Santhera Pharmaceuticals Holding AG77.19M
Newron Pharmaceuticals17.81M
BioVersys AG4.62M
Molecular Partners AG681.00K
Xlife Sciences AG275.31K
Revenue Rankings

MindMaze Therapeutics Holding News

More News